Late diabetic complications. Update on implementation of the St. Vincent goals;Diabetische spätschäden: Stand der umsetzung der St.-Vincent-ziele

Diabetologe

Volumn 6, Issue 3, 2010, Pages 190-195

  Icks, A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Diabetes mellitus; Incidences; Late complications; Relative and attributable risks; St. Vincent declaration

Indexed keywords

AMPUTATION; BLINDNESS; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; GROUPS BY AGE; HEART INFARCTION; HUMAN; INCIDENCE; KIDNEY FAILURE; LIFE EXPECTANCY; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; RISK REDUCTION;

EID: 77953426226     PISSN: 18609716     EISSN: 18609724     Source Type: Journal    
DOI: 10.1007/s11428-009-0499-5     Document Type: Review

References (37)

1. Abbott RD, Donahue RP (1987) Diabetes and the risk of stroke: the Honolulu Heart Program. JAMA 257:949-952
2. American Diabetes Association (1998) Standards of medical care for people with diabetes. Diabetes Care 21 (S1):S21-S32
3. Brancati FL, Whelton PK, Randall BL et al (1997) Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple risk factor intervention trial. JAMA 278(23):1069-1074
4. Berger M (Hrsg) (2000) Diabetes mellitus. Urban & Schwarzenberg, München
5. Berger M, Trautner C (Hrsg) (1996) Die Forderungen von St. Vincent - Stand 1996 in Deutschland. Kirchheim, Mainz
6. Boulton AJM (2008) The diabetic foot: grand overview, epidemiology, and pathogenesis. Diabetes Metab Res Rev 24 (S1):S3-S6
7. Bundesversicherungsamt, Disease Management Program (DMP) Diabetes mellitus. http://www.bundesversicherungsamt.de/cln-091/nn-1046648/DE/DMP/dmp- node.html?-nnn=true (downloaded: 17. Dezember, 2008)
8. Cowie CC, Port FK, Wolfe RA et al (1989) Disparities in incidence of end-stage renal disease according to race and type of diabetes. N Engl J Med 321(16):1074-1079
9. Deutsche Diabetes-Union (Hrsg) (2009) Evidenzbasierte Diabetes-Leitlinien DDG, Gesundheitsbericht Diabetes 2010. Kirchheim, Mainz
10. Diabetes care and research in Europe (1989) The Saint Vincent declaration. World Health Organization, ICP/CLR 034
11. Frei U, Schober-Halstenberg HJ (2006) Nierenersatztherapie in Deutschland. Bericht 2005/2006. QuaSi Niere
12. Giani G, Janka HU, Hauner H et al (2004) Epidemiologie und Verlauf des Diabetes mellitus in Deutschland. Evidenzbasierte Leitlinie der DDG, 2. aktualisierte Aufl. (gültig bis 2011). http://www.deutsche-diabetes- gesellschaft.de/redaktion/mitteilungen/leitlinien/EBL-Epidemiologie-Update-2004. pdf (accessed 06/03/2010)
13. Hatano S (1976) Experience from a multicenter stroke register: a preliminary report. Bull World Health Organ 54:541-553
14. Heller G, Günster C, Schellschmidt H (2004) Wie häufig sind diabetesbedingte Amputationen unterer Extremitäten in Deutschland? Dtsch Med Wochenschr 129:429-433
15. Heller G, Günster C, Swart E (2005) Über die Häufigkeit von Amputationen unterer Extremitäten in Deutschland. Dtsch Med Wochenschr 130:1689-1690
16. Icks A, Rathmann W, Rosenbauer J, Giani G (2005) Diabetes mellitus. Themenheft zur Gesundheitsbe-richterstattung in Deutschland. Robert-Koch-Institut (Hrsg), Berlin
17. Icks A, Haastert B, Trautner C et al (2009) Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. Findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes 117:500-504
18. Icks A, Dickhaus T, Hörmann A et al (2009) Lower incidence of myocardial infarction in non-diabetic subjects and in diabetic women, but not in diabetic men, in the population aged 25 to 74 years. Findings from the MONICA/KORA myocardial infarction registry in Southern Germany, 1985-2006. Diabetologia 52:1836-1841
19. Icks A, Haaster B, Ganjour A et al (2009) Costs of dialysis - a regional population-based analysis. Nephrol Dial Transplant [Epub ahead of print]
20. Icks A, Trautner C, Haastert B et al (1997) Blindness due to diabetes: Population-based age and sex-specific incidence rates. Diabet Med 14:571-575
21. Icks A, Trautner C (1996) Epidemiologie von Erblindungen, besonders bei Diabetes: Übersicht über vorliegende Studien. Gesundheitswesen 58:85-90 (Pubitemid 126485013)
22. Icks A, Trautner C (1996) Epidemiologie diabetes-bedingter Erblindungen: Übersicht über vorliegende Studien. Diabetes Stoffw 5:13-18
23. Köster I, Ferber L von, Ihle P et al (2006) The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM study. Diabetologia 9:1498-1504
24. Kries R von, Kimmerle R, Schmidt JE et al (1997) Pregnancy outcomes in mothers with pregestational diabetes: a population-based study in North Rhine (Germany) from 1988 to 1993. Eur J Pediatr 156:963-967
25. Löwel H, Stieber J, Koenig W et al (1999) Das diabetesbedingte Herzinfarktrisiko in einer süddeutschen Bevölkerung: Ergebnisse der MONICA-Augsburg-Studien 1985-1994. Diabetes Stoffw 8:11-21
26. Nebel M (2002) Behandlungskosten der Nierenersatztherapie in Deutschland 1999. Nieren- und Hochdruckkrankheiten 31:85-92
27. Pfannkuche MS, Schicktanz C (2007) Indikations-bereich Diabetes. In: Glaeske G, Janhsen K (Hrsg) GEK-Arzneimittel-Report 2007. Asgard, St. Augustin, S 177-225
28. Rodriguez BL, D'Agostino R, Abbott RD et al (2002) Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke 33:230-236
29. Standl E, Mendler G, Zimmermann R, Stiegler H (1996) Zur Amputationshäufigkeit von Diabetikern in Deutschland (Ergebnisse einer Erhebung in zwei Landkreisen). Diabetes Stoffw 5:29-32
30. Stieger H, Standl E, Frank S, Mendler G (1998) Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population-based surveys 1990 and 1998 in Germany. Vasa 27(1):10-14
31. Trautner C, Icks A, Haastert B et al (1997) Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 20:1147-1153 (Pubitemid 27274279)
32. Trautner C, Haastert B, Giani G, Berger M (1998) Amputations and diabetes: a case-control study. Diabet Med 19:35-40
33. Trautner C, Haastert B, Spraul M et al (2001) Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diabetes Care 24:855-859
34. Trautner C, Haastert B, Giani G, Berger M (2001) Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia 44:147-150
35. Trautner C, Haastert B, Richter B et al (2003) Incidence of blindness in Southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci 44:1131-1134
36. Trautner C, Haastert B, Mauckner P et al (2007) Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005. Results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 30:2633-2637
37. Ferber L von, Köster I, Hauner H (2007) Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM study. Exp Clin Endocrinol Diabetes 115:97-104